English, Article edition: Cost-Effectiveness Analysis of a Pharmacy Asthma Care Program in Australia Adam Gordois; Carol Armour; Martha Brillant; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/46505
Physical Description
  • article
Language
  • English

Edition details

Title
  • Cost-Effectiveness Analysis of a Pharmacy Asthma Care Program in Australia
Author
  • Adam Gordois
  • Carol Armour
  • Martha Brillant
  • Sinthia Bosnic-Anticevich
  • Deborah Burton
  • Lynne Emmerton
  • Ines Krass
  • Bandana Saini
  • Lorraine Smith
  • Kay Stewart
Physical Description
  • article
Notes
  • Objectives: A pharmacy asthma care program in Australia, which included specific education on asthma and asthma medication, trigger factors, use of inhalers, and medication adherence, as well as goal setting and patient review aspects, assessed the impact of a community pharmacy asthma service on the severity of patients' asthma over 6 months. Data from this study were used to estimate the cost effectiveness of the program. Methods: The intervention population was compared with a control population and results at 6 months were included in a Markov model in order to estimate the cost effectiveness over 5 years from the perspective of the Australian healthcare system. The model had a cycle length of 6 months and included transition probabilities for switching between classes of severity of asthma, the costs of asthma treatment and program delivery, and utility values for a patient's quality of life with asthma. Costs were Australian dollars ($A), year 2006 values, and both costs and benefits were discounted at a rate of 5% per annum. Results: Over the 5 years following an initial review, the program generated 0.131 additional quality-adjusted life-years (QALYs), at an additional net cost of $A623 if annual reviews were required to maintain asthma improvements (annual review scenario) or $A376 if annual reviews were not required (no annual review scenario), resulting in costs per QALY gained of $A4753 and $A2869, respectively. Conclusions: The program appears to be cost effective compared with no program, whether or not annual reviews were required to maintain improvements and under a range of other assumptions. Current evidence suggests that the pharmacy asthma care program should be implemented and funded for the treatment of adults with asthma in Australia.
  • Asthma, Cost-utility, Pharmaceutical-care-programmes
  • RePEc:wkh:dmhout:v:15:y:2007:i:6:p:387-396
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment